| ED North Database | | 2,2',4,4',5-Pentabromodiphenyl ether (BDE 99) |
| Study details | | Group | mammalian | | Organism | Human | | Tissue | | | Age | | | InVivo | In vitro | | Lab | Laboratory | | Flow | | | Duration | Overnight | | Route | | | Temperature | 4°C | | Concentration | Metabolites: max 250 nM | | Notes | Metabolization by incubation with rat hepatic microsomes prior to use; max concentration with 100% conversion; T4-transthyretin competition binding study |
|
|
| Described effects | | suspected no endocrine effect No significant displacement of T4 from transthyretin | | suspected no endocrine effect Parent PBDE: no binding to transthyretin |
|
| Literature references | | Meerts, I.L.T.M., van Zanden, J.J., Luijks, E.A.C., van Leeuwen-Bol, I., Marsh, G., Jakobsson, E., Bergman, A., Brouwer, A.(2000). Potent competitive interactions of some brominated flame retartands and related compounds with human transthyretin in vitro.Toxicol. Sci., 56: 95-104 |
|
|